Lucid Diligence Brief: Formation Bio licenses miR-124 activator FHND5032 from CTFH
Lucid Diligence Brief: Formation Bio licenses miR-124 activator FHND5032 from…
Lucid Diligence Brief: Boehringer Ingelheim and Simcere partner in IBD
Lucid Diligence Brief: Boehringer Ingelheim and Simcere partner in IBD…
Lucid Diligence Brief: Lilly to acquire Ventyx Biosciences
Lucid Diligence Brief: Lilly to acquire Ventyx Biosciences Professional…
Immunology Video Recap—October 22, 2025
In this video, we take a closer look at the newest updates in immunology. Watch…
Immunology Today—October 22, 2025
This week in Immunology: the latest clinical updates, regulatory news, industry…
Immunology Weekly News - October 1st 2025
Immunology Update: EndoQuest Robotics, $1.8M NIH grant, BMS Patient Connect and…
Immunology Weekly News - September 17th 2025
🔬 This week in Immunology Updates: Immunology Licensing Deal, Phase II SKYWAY…
Immunology Weekly News - August 27th 2025
🔬 This week in Immunology Updates: A pivotal biosimilar launch, regulatory…
Trending in Health Mobile Apps H1 2025
📊 Trending in Health Mobile Apps: Current Trends, Rankings and Insights from H1…
Immunology Weekly News - August 13th 2025
🧬 Immunology Updates: Policy shifts in IBD drug access, breakthrough results in…
Immunology Weekly News - May 7th 2025
🧠 This Week in Immunology: FDA Approvals, Gene Therapy Breakthroughs &…